Sureclick | Amgevita (adalimumab) Administration Device | Amgen


SURECLICK®, a device used by millions of patients, is designed to improve injection experience1

syringe device icon
Easy to use for patients,2* who want to retain control over their injection
meditation for anxiety icon
Patients never have to see a needle, potentially reducing anxiety3
patients icon
Patients can feel independent preparing and administrating their own treatments4

AMGEVITA® presentations offer flexible dosing across paediatric and adult indications4†


AMGEVITA® is the only adalimumab biosimilar available in a 20 mg presentation4

*Support for the device has been interpreted from commendations awarded to SURECLICK® for ENBREL®.
For full therapeutic indications, refer to the Summary of Product Characteristics.
  1. Data on File; Amgen. October 2017.
  2. ENBREL® (etanercept) Administration Options. Arthritis Foundation. Available at: Last accessed May 2020.
  3. AMGEVITA® (adalimumab) Package Leaflet. Available at: Last revised March 2020.
  4. AMGEVITA® (adalimumab) Summary of Product Characteristics. Available at: Last revised March 2020.

The information contained in this website is for European healthcare professionals only

I understand and confirm I am an EU healthcare professional
Read more >
I am not an EU healthcare professional
Read more >
▼This medicinal product is subject to additional monitoring. This will allow quick identification of new safety information. Healthcare professionals are asked to report any suspected adverse reactions.